A DOUBLE-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL TRIAL OF N-ACETYLCYSTEINE FOR PREVENTING AMPHOTERICIN B-INDUCED NEPHROTOXICITY

KARIMZADEH, I.. (2015). A DOUBLE-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL TRIAL OF N-ACETYLCYSTEINE FOR PREVENTING AMPHOTERICIN B-INDUCED NEPHROTOXICITY. EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY, 11(9), 1345-1355. SID. https://sid.ir/paper/709909/en

KARIMZADEH I.. A DOUBLE-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL TRIAL OF N-ACETYLCYSTEINE FOR PREVENTING AMPHOTERICIN B-INDUCED NEPHROTOXICITY. EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY[Internet]. 2015;11(9):1345-1355. Available from: https://sid.ir/paper/709909/en

I. KARIMZADEH, “A DOUBLE-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL TRIAL OF N-ACETYLCYSTEINE FOR PREVENTING AMPHOTERICIN B-INDUCED NEPHROTOXICITY,” EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY, vol. 11, no. 9, pp. 1345–1355, 2015, [Online]. Available: https://sid.ir/paper/709909/en